BR0115301A - Uso de um inibidor seletivo da recaptação de norepinefrina - Google Patents

Uso de um inibidor seletivo da recaptação de norepinefrina

Info

Publication number
BR0115301A
BR0115301A BR0115301-3A BR0115301A BR0115301A BR 0115301 A BR0115301 A BR 0115301A BR 0115301 A BR0115301 A BR 0115301A BR 0115301 A BR0115301 A BR 0115301A
Authority
BR
Brazil
Prior art keywords
selective norepinephrine
norepinephrine reuptake
reuptake inhibitor
selective
inhibitor
Prior art date
Application number
BR0115301-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Holly Read Thomasson
David Michelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR0115301A publication Critical patent/BR0115301A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR0115301-3A 2000-11-15 2001-11-06 Uso de um inibidor seletivo da recaptação de norepinefrina BR0115301A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24901000P 2000-11-15 2000-11-15
US26536201P 2001-01-31 2001-01-31
PCT/US2001/027801 WO2002040006A2 (en) 2000-11-15 2001-11-06 Treatment of anxiety disorders

Publications (1)

Publication Number Publication Date
BR0115301A true BR0115301A (pt) 2004-12-14

Family

ID=26939750

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0115301-3A BR0115301A (pt) 2000-11-15 2001-11-06 Uso de um inibidor seletivo da recaptação de norepinefrina

Country Status (16)

Country Link
EP (1) EP1395253A2 (de)
JP (1) JP2004529073A (de)
KR (1) KR20030051812A (de)
CN (1) CN1822825A (de)
AU (1) AU2002217757A1 (de)
BR (1) BR0115301A (de)
CA (1) CA2426069A1 (de)
CZ (1) CZ20031339A3 (de)
EA (1) EA200300567A1 (de)
HR (1) HRP20030384A2 (de)
IL (1) IL155874A0 (de)
MX (1) MXPA03004190A (de)
NO (1) NO20032156L (de)
PL (1) PL366119A1 (de)
SK (1) SK5422003A3 (de)
WO (1) WO2002040006A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60226715D1 (de) * 2001-03-06 2008-07-03 Lilly Co Eli Monoamin-aufnahme-inhibitor
NZ537521A (en) * 2002-08-14 2007-05-31 Pharmacia & Upjohn Co Llc Use of reboxetine for the treatment of hot flashes
GB0309440D0 (en) * 2003-04-25 2003-06-04 Lilly Co Eli Quinolone derivatives
WO2004103356A2 (en) * 2003-05-15 2004-12-02 Eli Lilly And Company Treatment of emotional dysregulation
CN1889940A (zh) * 2003-12-12 2007-01-03 伊莱利利公司 热潮红、冲动控制障碍和全身性医学病症引起的人格变化的治疗
EP2234960A2 (de) 2008-01-09 2010-10-06 Mayo Foundation for Medical Education and Research Hemmung der wiederaufnahme von neurotransmittern
WO2011056788A2 (en) * 2009-11-03 2011-05-12 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
WO2011056773A2 (en) * 2009-11-03 2011-05-12 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
WO2014159251A2 (en) 2013-03-14 2014-10-02 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
CN113710319B (zh) * 2019-02-01 2024-10-11 霍夫曼技术有限责任公司 用于治疗焦虑相关病症的组合物和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997041878A1 (en) * 1996-05-07 1997-11-13 Merck & Co., Inc. Treatment of mood disorders with a growth hormone secretagogue
IT1305322B1 (it) * 1998-04-23 2001-05-04 Pharmacia & Upjohn Spa Uso di reboxetina per il trattamento di disturbi nervosi
ES2246488T3 (es) * 1999-07-01 2006-02-16 PHARMACIA & UPJOHN COMPANY LLC Reboxetina para tratar la migraña.

Also Published As

Publication number Publication date
JP2004529073A (ja) 2004-09-24
CA2426069A1 (en) 2002-05-23
AU2002217757A1 (en) 2002-05-27
NO20032156D0 (no) 2003-05-13
KR20030051812A (ko) 2003-06-25
CZ20031339A3 (cs) 2003-10-15
WO2002040006A2 (en) 2002-05-23
PL366119A1 (en) 2005-01-24
SK5422003A3 (en) 2003-12-02
WO2002040006A3 (en) 2003-12-24
HRP20030384A2 (en) 2003-08-31
NO20032156L (no) 2003-05-13
CN1822825A (zh) 2006-08-23
EP1395253A2 (de) 2004-03-10
EA200300567A1 (ru) 2004-10-28
IL155874A0 (en) 2003-12-23
MXPA03004190A (es) 2003-09-22

Similar Documents

Publication Publication Date Title
BR0112786A (pt) Inibidores de inflamação não-esteroidais
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
IT1317757B1 (it) Metodo per la preparazione di idrocarburi idrogenati.
NO20016406L (no) Höyselektive reopptaksinhibitorer for norepinefrin
MY134110A (en) Combinations of reboxetine and neuroleptic agents
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
WO2004047830A3 (de) Pharmazeutische zusammensetzung aus einem beta-3-adrenozeptor-agonisten und einem serotonin- und/oder norepinephrin-reuptake-inhibitor deren verwendung zur behandlung von blasenfunktionsstörungen
DZ3192A1 (fr) Dérivés de diaryl ether utilises comme inhibiteursdu recaptage de monoamines.
BR0112292A (pt) Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto
BR0017343B1 (pt) processo para dessalinização da água do mar.
IS6003A (is) Mónóamín endurupptökulatar til meðhöndlunar á truflunum í miðtaugakerfi
PT1259512E (pt) Compostos de pteridin para o tratamento da psoriase
HN2001000217A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
NO20030842L (no) Fenoksybenzylaminderivater som selektive serotonin- gjenopptaksinhibitorer
DE60206164D1 (de) Trisubstituierte-n-((1s)-1,2,3,4-tetrahydro-1-naphthalenyl) benzamide welche p2x3 und p2x2/3 enthaltende rezeptoren inhibieren
BR0213581A (pt) Uso de um inibidor de recaptação de norepinefrina seletivo
WO2001066101A3 (en) Treatment of psoriasis
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
WO2002040006A3 (en) Treatment of anxiety disorders
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
DK1161239T3 (da) 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose
UY26556A1 (es) Compuestos calcilíticos
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
BR0101437A (pt) Método para preparar um ciclopropeno
BRPI0412268A (pt) compostos contendo um inibidor seletivo da recaptação de serotonina e antagonista de receptor 5-ht2a

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS.